Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testingmarketing2021-02-17T18:10:07+00:00November 17th, 2020|2020 Publications, Featured Publications, Publications| 続きを読む
Plasticity of the human IgM repertoire in response to long‐term spaceflightmarketing2021-02-11T20:09:45+00:00October 13th, 2020|2020 Publications, Featured Publications, Publications| 続きを読む
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasmsmarketing2021-02-11T23:46:14+00:00March 21st, 2019|2019 Publications, Featured Publications, Publications| 続きを読む
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutationsmarketing2021-02-11T23:49:39+00:00August 25th, 2018|2018 Publications, Featured Publications, Publications| 続きを読む
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALLmarketing2021-02-11T23:54:51+00:00August 22nd, 2018|2018 Publications, Featured Publications, Publications| 続きを読む
Targeted Deep Sequencing Reveals Clinically Relevant Subclonal IgHV Rearrangements in Chronic Lymphocytic Leukemiamarketing2021-02-12T18:36:01+00:00October 31st, 2016|2016 Publications, Featured Publications, Publications| 続きを読む
